| 2026 |
PHENO-RAG: An artificial intelligence tool for guideline-informed management decisions in hepatocellular carcinoma |
Articolo in rivista |
Vai |
| 2025 |
The application of artificial intelligence-based tools in the management of hepatocellular carcinoma: current status and future perspectives |
Articolo in rivista |
Vai |
| 2025 |
A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs) |
Review essay (rassegna critica) |
Vai |
| 2025 |
A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta-Analysis |
Articolo in rivista |
Vai |
| 2024 |
Are we ready for genetic testing in metabolic dysfunction-associated steatotic liver disease? |
Review essay (rassegna critica) |
Vai |
| 2023 |
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2023 |
Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line |
Articolo in rivista |
Vai |
| 2023 |
MAFLD: a multisystem disease |
Recensione in rivista |
Vai |
| 2022 |
Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis |
Articolo in rivista |
Vai |
| 2022 |
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development |
Articolo in rivista |
Vai |
| 2022 |
Hepatitis C: Standard of Treatment and What to Do for Global Elimination |
Articolo in rivista |
Vai |
| 2022 |
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2022 |
AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD |
Articolo in rivista |
Vai |
| 2022 |
The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints |
Articolo in rivista |
Vai |
